Fintel reports that on September 19, 2023, Cantor Fitzgerald reiterated coverage of Insmed (NASDAQ:INSM) with a Overweight recommendation. Analyst Price Forecast Suggests 56.63% Upside
Fintel reports that on September 19, 2023, HC Wainwright & Co. reiterated coverage of Regulus Therapeutics (NASDAQ:RGLS) with a Buy recommendation. Analyst Price Forecast Suggests 242.07% Upside
Fintel reports that on September 19, 2023, JMP Securities initiated coverage of Ryan Specialty Holdings Inc (NYSE:RYAN) with a Market Perform recommendation.
Fintel reports that on September 19, 2023, Goldman Sachs initiated coverage of Interactive Brokers Group Inc - (NASDAQ:IBKR) with a Neutral recommendation.
Fintel reports that on September 19, 2023, Jefferies initiated coverage of WNS Holdings Limited - ADR (NYSE:WNS) with a Buy recommendation.
Fintel reports that on September 19, 2023, TD Cowen initiated coverage of Aurora Innovation Inc - (NASDAQ:AUR) with a Market Perform recommendation.
Fintel reports that on September 19, 2023, Wedbush reiterated coverage of Block Inc - (NYSE:SQ) with a Neutral recommendation. Analyst Price Forecast Suggests 68.99% Upside
Fintel reports that on September 19, 2023, Goldman Sachs maintained coverage of Micron Technology (NASDAQ:MU) with a Buy recommendation. Analyst Price Forecast Suggests 8.56% Upside
Fintel reports that on September 19, 2023, Truist Securities initiated coverage of Praxis Precision Medicines (NASDAQ:PRAX) with a Buy recommendation.
Fintel reports that on September 19, 2023, Citigroup initiated coverage of Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Neutral recommendation. Analyst Price Forecast Suggests 112.26% Upside
Fintel reports that on September 19, 2023, Telsey Advisory Group maintained coverage of Stitch Fix Inc - (NASDAQ:SFIX) with a Market Perform recommendation.
Fintel reports that on September 19, 2023, Citigroup maintained coverage of General Dynamics (NYSE:GD) with a Buy recommendation. Analyst Price Forecast Suggests 20.20% Upside
Fintel reports that on September 19, 2023, CJS Securities initiated coverage of Stevanato Group (NYSE:STVN) with a Market Outperform recommendation.